IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas

Histopathology

Volumn 61, Issue 5, 2012, Pages 930-941

  Falini, Brunangelo ^a   Agostinelli, Claudio ^b   Bigerna, Barbara ^a   Pucciarini, Alessandra ^a   Pacini, Roberta ^a   Tabarrini, Alessia ^a   Falcinelli, Flavio ^a   Piccioli, Milena ^b   Paulli, Marco ^c   Gambacorta, Marcello ^d   Ponzoni, Maurilio ^e   Tiacci, Enrico ^a   Ascani, Stefano ^f   Martelli, Maria Paola ^a   Favera, Riccardo Dalla ^g   Stein, Harald ^h   Pileri, Stefano A ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d Ospedale Niguarda Ca'   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f University of Terni   (Italy)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h Pathodiagnostik Berlin   (Germany)

Author keywords

Immunohistochemistry; IRTA1; Marginal zone lymphomas; Monoclonal antibodies

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN SUPERFAMILY RECEPTOR TRANSLOCATION ASSOCIATED 1; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER GROWTH; CELL DIFFERENTIATION; EPITHELIUM; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MARGINAL ZONE LYMPHOMA; NODAL MARGINAL ZONE LYMPHOMA; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TUMOR CELL; TUMOR DIFFERENTIATION;

B-LYMPHOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; RECEPTORS, FC; SPLEEN; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84868136434     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04289.x     Document Type: Article

References (40)

1. Swerdlow S, Campo E, Harris NL et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Geneva: IARC Press, 2008.
2. Hatzivassiliou G, Miller I, Takizawa J et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001; 14; 277-289.
3. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R. IRTAs: a new family of immunoglobulin-like receptors differentially expressed in B cells. Blood 2002; 99; 2662-2669.
4. Davis RS, Wang YH, Kubagawa H, Cooper MD. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 2001; 98; 9772-9777.
5. Maltais LJ, Lovering RC, Taranin AV et al. New nomenclature for Fc receptor-like molecules. Nat. Immunol. 2006; 7; 431-432.
6. Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 1990; 248; 732-735.
7. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290; 84-89.
8. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol. Today 1994; 15; 490-495.
9. Falini B, Tiacci E, Pucciarini A et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 2003; 102; 3684-3692.
10. Isaacson PG, Norton AJ. Mucosa-associated lymphoid tissue (MALT) and the MALT lymphoma concept. In: Isaacson PG, Norton AJ, eds. Extranodal Lymphomas. Edinburgh: Churchill Livingstone, 1994; 5-14.
11. Sheibani K, Fritz RM, Winberg CD, Burke JS, Rappaport H. 'Monocytoid' cells in reactive follicular hyperplasia with and without multifocal histiocytic reactions: an immunohistochemical study of 21 cases including suspected cases of toxoplasmic lymphadenitis. Am. J. Clin. Pathol. 1984; 81; 453-458.
12. Stein H, Lennert K, Mason DY, Liangru S, Ziegler A. Immature sinus histiocytes. Their identification as a novel B-cell population. Am. J. Pathol. 1984; 117; 44-52.
13. Kojima M, Nakamura S, Itoh H et al. Occurrence of monocytoid B-cells in reactive lymph node lesions. Pathol. Res. Pract. 1998; 194; 559-565.
14. Falini B, Fizzotti M, Pucciarini A et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000; 95; 2084-2092.
15. Flenghi L, Bigerna B, Fizzotti M et al. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am. J. Pathol. 1996; 148; 1543-1555.
16. Went P, Agostinelli C, Gallamini A et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J. Clin. Oncol. 2006; 24; 2472-2479.
17. Pileri SA, Roncador G, Ceccarelli C et al. Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J. Pathol. 1997; 183; 116-123.
18. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984; 32; 219-229.
19. Haralambieva E, Banham AH, Bastard C et al. Detection by the fluorescence insitu hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples. Br. J. Haematol. 2003; 121; 49-56.
20. Ventura RA, Martin-Subero JI, Jones M et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J. Mol. Diagn. 2006; 8; 141-151.
21. Campo E, Pileri S, Jaffe ES, Muller-Hermelink HK, Nathwani BN. Nodal marginal zone lymphoma. In Swerdlow SH et al. eds. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Geneva: IARC Press, 2008; 218-219.
22. Rinaldi A, Mian M, Chigrinova E et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 2010; 117; 1595-1604.
23. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52; 1410-1416.
24. Isaacson PG, Chott A, Nakamura S, Muller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In Swerdlow SH et al. eds. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Geneva: IARC Press, 2008; 214-217.
25. Garcia M, Konoplev S, Morosan C, Abruzzo LV, Bueso-Ramos CE, Medeiros LJ. MALT lymphoma involving the kidney: a report of 10 cases and review of the literature. Am. J. Clin. Pathol. 2007; 128; 464-473.
26. Isaacson PG, Chan JK, Tang C, Addis BJ. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitisf. Am. J. Surg. Pathol. 1990; 14; 342-351.
27. Takagi N, Nakamura S, Yamamoto K et al. Malignant lymphoma of mucosa-associated lymphoid tissue arising in the thymus of a patient with Sjogren's syndrome. A morphologic, phenotypic, and genotypic study. Cancer 1992; 69; 1347-1355.
28. Mosnier JF, Brousse N, Sevestre C et al. Primary low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue arising in the gallbladder. Histopathology 1992; 20; 273-275.
29. van den Oord JJ, de Wolf-Peeters C, Desmet VJ. The marginal zone in the human reactive lymph node. Am. J. Clin. Pathol. 1986; 86; 475-479.
30. Stein K, Hummel M, Korbjuhn P et al. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood 1999; 94; 2800-2808.
31. Camacho FI, Garcia JF, Sanchez-Verde L et al. Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma. Am. J. Pathol. 2001; 158; 1363-1369.
32. Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H. Monocytoid B-cell lymphoma. A novel B-cell neoplasm. Am. J. Pathol. 1986; 124; 310-318.
33. Dono M, Burgio VL, Tacchetti C et al. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur. J. Immunol. 1996; 26; 2035-2042.
34. Dono M, Zupo S, Augliera A et al. Subepithelial B cells in the human palatine tonsil. II. Functional characterization. Eur. J. Immunol. 1996; 26; 2043-2049.
35. Dono M, Zupo S, Massara R et al. Invitro stimulation of human tonsillar subepithelial B cells: requirement for interaction with activated T cells. Eur. J. Immunol. 2001; 31; 752-756.
36. Lazzi S, Bellan C, Tiacci E et al. IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. J. Pathol. 2006; 209; 56-66.
37. Mebius RE, Nolte MA, Kraal G. Development and function of the splenic marginal zone. Crit. Rev. Immunol. 2004; 24; 449-464.
38. Spencer J, Perry ME, Dunn-Walters DK. Human marginal-zone B cells. Immunol. Today 1998; 19; 421-426.
39. Attygalle AD, Liu H, Shirali S et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 2004; 104; 3343-3348.
40. Kojima M, Morita Y, Shimizu K et al. Immunohistological findings of suppurative granulomas of Yersinia enterocolitica appendicitis: a report of two cases. Pathol. Res. Pract. 2007; 203; 115-119.